Clinical Trial Update: A Study to Evaluate Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multiforme (BRAIN) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab alone or in combination with irinotecan for glioblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Genentech, Inc. | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED